Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-052064
Filing Date
2021-08-17
Accepted
2021-08-17 19:21:48
Documents
2
Period of Report
2021-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4596
2 POA DOCUMENT poa.txt EX-24.3_1004489 3133
  Complete submission text file 0001209191-21-052064.txt   9144
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Issuer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110 CARLSBAD CA 92011
Business Address
Giangiulio Dawn (Reporting) CIK: 0001878142 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40288 | Film No.: 211184564